Janus kinase - Alchetron, The Free Social Encyclopedia
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect
JAK阻害 | JAK Inhibition
JAK–STAT pathway targeting for the treatment of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
Development of piperidinyl dipyrrrolopyridine-based dual inhibitors of Janus kinase and Bruton's tyrosine kinase: a potential therapeutic probability to deal with rheumatoid arthritis | SpringerLink
Rheumatoid arthritis | JAK inhibitors: The next generation of drugs for treating rheumatoid arthritis? | rheumatology.medicinematters.com
IJMS | Free Full-Text | Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis | HTML
Janus kinase - Wikiwand
Calming The Cytokine Storm Through Kinase Inhibition | News & Announcements | Cayman Chemical
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases - Journal of Allergy and Clinical Immunology
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application | Biomarker Research | Full Text
Janus kinase 3 inhibitor - Wikiwand
JAK, an Oncokinase in Hematological Cancer | IntechOpen
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology
Figure 1 | JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors | SpringerLink